Literature DB >> 32950646

Silymarin is an ally against insulin resistance: A review.

Karla MacDonald-Ramos1, Layla Michán2, Alejandra Martínez-Ibarra1, Marco Cerbón3.   

Abstract

Silymarin is obtained from the Milk thistle plant Silybum marianum and has been used over the centuries to treat principally liver disease, although it has also been studied for its beneficial effects in cardioprotection, neuroprotection, immune modulation, and cancer among others. Importantly, silymarin's active component silybin is a flavonolignan that exhibits different activities such as; scavenger, anti-oxidant, anti-inflammatory, and recently revealed, insulin-sensitizing properties which have been explored in clinical trials in patients with insulin resistance. In this review, we summarize the most relevant research of silymarin's effect on lipid and carbohydrate metabolism, focusing the attention on insulin resistance, which is well known to play a crucial role in metabolic disease progression.
Copyright © 2020 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Clinical trials; Diabetes; Insulin resistance; Liver disease; Obesity; Silymarin

Mesh:

Substances:

Year:  2020        PMID: 32950646     DOI: 10.1016/j.aohep.2020.08.072

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  5 in total

1.  Local Insulin-Derived Amyloidosis Model Confronted with Silymarin: Histological Insights and Gene Expression of MMP, TNF-α, and IL-6.

Authors:  Katia Azarfar; Parichehreh Yaghmaei; Mahsa M Amoli; Nasim Hayati-Roodbari; Azadeh Ebrahim-Habibi
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

2.  Experimental Design and Optimization of Nano-Transfersomal Gel to Enhance the Hypoglycemic Activity of Silymarin.

Authors:  Marwa H Abdallah; Amr S Abu Lila; Seham Mohammed Shawky; Khaled Almansour; Farhan Alshammari; El-Sayed Khafagy; Tarek Saad Makram
Journal:  Polymers (Basel)       Date:  2022-01-27       Impact factor: 4.329

3.  SIRT3 Modulates Endothelial Mitochondrial Redox State during Insulin Resistance.

Authors:  Elisa Martino; Anna Balestrieri; Camilla Anastasio; Martina Maione; Luigi Mele; Domenico Cautela; Giuseppe Campanile; Maria Luisa Balestrieri; Nunzia D'Onofrio
Journal:  Antioxidants (Basel)       Date:  2022-08-19

4.  The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model.

Authors:  Martina Hüttl; Irena Markova; Denisa Miklankova; Iveta Zapletalova; Martin Poruba; Zuzana Racova; Rostislav Vecera; Hana Malinska
Journal:  Pharmaceutics       Date:  2021-12-27       Impact factor: 6.321

5.  The Symbiotic Effect of a New Nutraceutical with Yeast β-Glucan, Prebiotics, Minerals, and Silybum marianum (Silymarin) for Recovering Metabolic Homeostasis via Pgc-1α, Il-6, and Il-10 Gene Expression in a Type-2 Diabetes Obesity Model.

Authors:  Aline Boveto Santamarina; Ruan Carlos Macêdo Moraes; Victor Nehmi Filho; Gilson Masahiro Murata; Jéssica Alves de Freitas; Danielle Araujo de Miranda; Anderson Romério Azevedo Cerqueira; Soraia Katia Pereira Costa; Ana Flávia Fernandes Ferreira; Luiz Roberto Britto; Juliana Alves de Camargo; Daniela Rodrigues de Oliveira; Flavia Neto de Jesus; José Pinhata Otoch; Ana Flávia Marçal Pessoa
Journal:  Antioxidants (Basel)       Date:  2022-02-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.